Improving Anti-PD-1/PD-L1 Therapy for Localized Bladder Cancer

In high-risk non-muscle invasive bladder cancer (HR-NMIBC), patient outcome is negatively affected by lack of response to Bacillus-Calmette Guérin (BCG) treatment. Lack of response to cisplatin-based neoadjuvant chemotherapy and cisplatin ineligibility reduces successful treatment outcomes in muscle...

Descripción completa

Detalles Bibliográficos
Autores principales: de Jong, Florus C., Rutten, Vera C., Zuiverloon, Tahlita C. M., Theodorescu, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998260/
https://www.ncbi.nlm.nih.gov/pubmed/33802033
http://dx.doi.org/10.3390/ijms22062800

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998260/
https://www.ncbi.nlm.nih.gov/pubmed/33802033
http://dx.doi.org/10.3390/ijms22062800

Ejemplares similares